Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Turner

Showing results (111-120 of 362) with videos related to

Pageof 37
Sort By:
Inflammatory Bowel Diseases|May 10, 2012
Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS RegistryArie Levine, Charlotte I de Bie, Dan Turner, et al.
Digestive Diseases and Sciences|January 7, 2014
Thiopurine S-methyltransferase (TPMT) activity is better determined by biochemical assay versus genotyping in the Jewish populationYair Kasirer, Rephael Mevorach, Paul Renbaum, et al.
Infectious Diseases and Therapy|August 1, 2022
HIV DNA Sequencing to Detect Archived Antiretroviral Drug ResistanceAnna Maria Geretti, Jose Luis Blanco, Anne Genevieve Marcelin, et al.
The American Journal of Gastroenterology|May 31, 2008
Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristicsEric I Benchimol, Dan Turner, Erika H Mann, et al.
Gastroenterology Research and Practice|July 19, 2019
Initial Development and Validation of a Transition Readiness Scale for Adolescents with Inflammatory Bowel DiseaseOded Hammerman, Areej Bayatra, Dan Turner, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 11, 2012
Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel diseaseDan Turner, Victorien M Wolters, Richard K Russell, et al.
Journal of Clinical Epidemiology|October 6, 2009
The minimal detectable change cannot reliably replace the minimal important differenceDan Turner, Holger J Schünemann, Lauren E Griffith, et al.
Gut|May 23, 2014
Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitisAmir Schechter, Christopher Griffiths, Juan Cristóbal Gana, et al.
Journal of Clinical Gastroenterology|October 17, 2025
Effectiveness of an Infliximab Biosimilar vs. Originator in Inflammatory Bowel Diseases: A Noninferiority Nationwide Study From the epi-IIRNHadas Labrisch-Kaye, Rachel Buchuk, Yiska Weisband, et al.
Frontiers in Pediatrics|November 15, 2021
Pediatric Gastrointestinal Endoscopy: Diagnostic Yield and Appropriateness of Referral Based on Clinical Presentation: A Pilot StudyTahel Fachler, Eyal Shteyer, Esther Orlanski Meyer, et al.
Pageof 37

Showing results (111-120 of 362) with videos related to

Sort By:
Pageof 37
Inflammatory Bowel Diseases|May 10, 2012
Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS RegistryArie Levine, Charlotte I de Bie, Dan Turner, et al.
Digestive Diseases and Sciences|January 7, 2014
Thiopurine S-methyltransferase (TPMT) activity is better determined by biochemical assay versus genotyping in the Jewish populationYair Kasirer, Rephael Mevorach, Paul Renbaum, et al.
Infectious Diseases and Therapy|August 1, 2022
HIV DNA Sequencing to Detect Archived Antiretroviral Drug ResistanceAnna Maria Geretti, Jose Luis Blanco, Anne Genevieve Marcelin, et al.
The American Journal of Gastroenterology|May 31, 2008
Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristicsEric I Benchimol, Dan Turner, Erika H Mann, et al.
Gastroenterology Research and Practice|July 19, 2019
Initial Development and Validation of a Transition Readiness Scale for Adolescents with Inflammatory Bowel DiseaseOded Hammerman, Areej Bayatra, Dan Turner, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 11, 2012
Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel diseaseDan Turner, Victorien M Wolters, Richard K Russell, et al.
Journal of Clinical Epidemiology|October 6, 2009
The minimal detectable change cannot reliably replace the minimal important differenceDan Turner, Holger J Schünemann, Lauren E Griffith, et al.
Gut|May 23, 2014
Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitisAmir Schechter, Christopher Griffiths, Juan Cristóbal Gana, et al.
Journal of Clinical Gastroenterology|October 17, 2025
Effectiveness of an Infliximab Biosimilar vs. Originator in Inflammatory Bowel Diseases: A Noninferiority Nationwide Study From the epi-IIRNHadas Labrisch-Kaye, Rachel Buchuk, Yiska Weisband, et al.
Frontiers in Pediatrics|November 15, 2021
Pediatric Gastrointestinal Endoscopy: Diagnostic Yield and Appropriateness of Referral Based on Clinical Presentation: A Pilot StudyTahel Fachler, Eyal Shteyer, Esther Orlanski Meyer, et al.
Pageof 37